ITRM
Iterum Therapeutics PLC
Price Chart
No historical data available
Latest Quote
$0.03
Current Price| Open | $0.04 |
| Day High | $0.05 |
| Day Low | $0.03 |
| Volume | 49,297,937 |
Stock Information
| Shares Outstanding | 53.29M |
| Total Debt | $33.73M |
| Cash Equivalents | $11.00M |
| Revenue | $390K |
| Net Income | $-26.96M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.60M |
| EPS (TTM) | $-0.72 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Iterum Therapeutics PLC
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
đ° Latest News
Iterum Therapeutics plc (NASDAQ:ITRM): Are Analysts Optimistic?
Simply Wall St. âĸ 2026-04-01T11:20:21Z
Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ...
GuruFocus.com âĸ 2025-11-14T21:01:51Z
Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long
Simply Wall St. âĸ 2025-10-17T14:41:47Z
Iterum Therapeutics sees cash runway into 2026
TipRanks âĸ 2025-09-20T12:10:43Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $254,000 | $0 | $0 | - |
| Cost Of Revenue | $254,000 | $0 | $0 | - |
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $2,522,000 | $1,428,000 | $2,361,000 | $5,553,000 |
| Total Expenses | $18,696,000 | $47,468,000 | $30,383,000 | $24,537,000 |
| Other Income Expense | $-3,316,000 | $11,138,000 | $-11,389,000 | $-60,769,000 |
| Other Non Operating Income Expenses | $-47,000 | $82,000 | $-16,847,000 | $195,000 |
| Net Non Operating Interest Income Expense | $-2,522,000 | $-1,428,000 | $-2,361,000 | $-5,553,000 |
| Interest Expense Non Operating | $2,522,000 | $1,428,000 | $2,361,000 | $5,553,000 |
| Operating Expense | $18,442,000 | $47,468,000 | $30,383,000 | $24,537,000 |
| General And Administrative Expense | $7,984,000 | $7,476,000 | $12,766,000 | $13,825,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Net Interest Income | $-2,522,000 | $-1,428,000 | $-2,361,000 | $-5,553,000 |
| Normalized Income | $-21,913,625 | $-48,045,000 | $-49,209,750 | $-38,220,500 |
| Net Income From Continuing And Discontinued Operation | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Total Operating Income As Reported | $-18,696,000 | $-47,468,000 | $-30,383,000 | $-24,537,000 |
| Net Income Common Stockholders | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Net Income | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Net Income Including Noncontrolling Interests | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Net Income Continuous Operations | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Pretax Income | $-24,534,000 | $-37,758,000 | $-44,133,000 | $-90,859,000 |
| Operating Income | $-18,696,000 | $-47,468,000 | $-30,383,000 | $-24,537,000 |
| Gross Profit | $-254,000 | $0 | $0 | - |
| Special Income Charges | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $-1.26 | $-2.73 | $-3.35 | $-7.74 |
| Basic EPS | $-1.26 | $-2.73 | $-3.35 | $-7.74 |
| Other | ||||
| Tax Effect Of Unusual Items | $-408,625 | $1,382,000 | $682,250 | $-7,620,500 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-18,459,000 | $-45,636,000 | $-45,430,000 | $-22,238,000 |
| Total Unusual Items | $-3,269,000 | $11,056,000 | $5,458,000 | $-60,964,000 |
| Total Unusual Items Excluding Goodwill | $-3,269,000 | $11,056,000 | $5,458,000 | $-60,964,000 |
| Reconciled Depreciation | $284,000 | $1,750,000 | $1,800,000 | $2,104,000 |
| EBITDA (Bullshit earnings) | $-21,728,000 | $-34,580,000 | $-39,972,000 | $-83,202,000 |
| EBIT | $-22,012,000 | $-36,330,000 | $-41,772,000 | $-85,306,000 |
| Diluted Average Shares | $19,699,260 | $14,059,862 | $13,272,658 | $11,813,315 |
| Basic Average Shares | $19,699,260 | $14,059,862 | $13,272,658 | $11,813,315 |
| Diluted NI Availto Com Stockholders | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Tax Provision | $240,000 | $613,000 | $301,000 | $705,000 |
| Gain On Sale Of Security | $-3,269,000 | $11,056,000 | $5,458,000 | $-60,964,000 |
| Research And Development | $10,458,000 | $39,992,000 | $17,617,000 | $10,712,000 |
| Selling General And Administration | $7,984,000 | $7,476,000 | $12,766,000 | $13,825,000 |
| Other Gand A | $4,798,000 | $3,858,000 | $6,613,000 | $8,955,000 |
| Salaries And Wages | $3,186,000 | $3,618,000 | $6,153,000 | $4,870,000 |
Fetched: 2026-03-28
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-23,827,000 | $-6,403,000 | $26,280,000 | $46,799,000 |
| Total Assets | $44,595,000 | $26,259,000 | $66,833,000 | $91,509,000 |
| Total Non Current Assets | $19,808,000 | $663,000 | $4,389,000 | $8,243,000 |
| Other Non Current Assets | $39,000 | $612,000 | $2,601,000 | $4,717,000 |
| Goodwill And Other Intangible Assets | $19,746,000 | $0 | $1,719,000 | $3,435,000 |
| Current Assets | $24,787,000 | $25,596,000 | $62,444,000 | $83,266,000 |
| Other Current Assets | $65,000 | - | - | - |
| Prepaid Assets | $531,000 | $1,433,000 | $1,220,000 | $680,000 |
| Receivables | $66,000 | $233,000 | $420,000 | $1,205,000 |
| Taxes Receivable | $66,000 | $233,000 | $420,000 | $915,000 |
| Cash Cash Equivalents And Short Term Investments | $24,125,000 | $23,930,000 | $60,804,000 | $81,381,000 |
| Cash And Cash Equivalents | $24,125,000 | $6,071,000 | $21,092,000 | $27,446,000 |
| Accrued Interest Receivable | - | - | $55,000 | $290,000 |
| Restricted Cash | - | - | - | $0 |
| Debt | ||||
| Net Debt | $21,409,000 | $12,885,000 | $7,374,000 | - |
| Total Debt | $45,534,000 | $18,956,000 | $28,466,000 | $26,525,000 |
| Long Term Debt And Capital Lease Obligation | $31,071,000 | $18,956,000 | $28,466,000 | $24,898,000 |
| Long Term Debt | $31,071,000 | $18,956,000 | $28,466,000 | $24,898,000 |
| Current Debt And Capital Lease Obligation | $14,463,000 | - | - | $1,627,000 |
| Current Debt | $14,463,000 | - | - | $1,627,000 |
| Other Current Borrowings | $14,463,000 | - | - | $1,627,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $48,676,000 | $32,662,000 | $38,834,000 | $41,275,000 |
| Total Non Current Liabilities Net Minority Interest | $31,071,000 | $19,144,000 | $29,770,000 | $28,334,000 |
| Current Liabilities | $17,605,000 | $13,518,000 | $9,064,000 | $12,941,000 |
| Other Current Liabilities | $240,000 | $761,000 | $1,944,000 | $9,050,000 |
| Payables And Accrued Expenses | $2,902,000 | $12,757,000 | $7,120,000 | $2,264,000 |
| Payables | $251,000 | $4,996,000 | $2,774,000 | $1,099,000 |
| Accounts Payable | $251,000 | $4,996,000 | $2,774,000 | $878,000 |
| Other Non Current Liabilities | - | $188,000 | $1,304,000 | $3,436,000 |
| Total Tax Payable | - | - | $0 | $221,000 |
| Income Tax Payable | - | - | $0 | $221,000 |
| Equity | ||||
| Common Stock Equity | $-4,081,000 | $-6,403,000 | $27,999,000 | $50,234,000 |
| Total Equity Gross Minority Interest | $-4,081,000 | $-6,403,000 | $27,999,000 | $50,234,000 |
| Stockholders Equity | $-4,081,000 | $-6,403,000 | $27,999,000 | $50,234,000 |
| Gains Losses Not Affecting Retained Earnings | $0 | $1,000 | $-350,000 | $0 |
| Retained Earnings | $-486,072,000 | $-461,298,000 | $-422,927,000 | $-378,493,000 |
| Other Equity Adjustments | - | $1,000 | $-350,000 | - |
| Other | ||||
| Ordinary Shares Number | $31,534,233 | $14,641,939 | $13,665,345 | $13,216,702 |
| Share Issued | $31,534,233 | $14,641,939 | $13,665,345 | $13,216,702 |
| Tangible Book Value | $-23,827,000 | $-6,403,000 | $26,280,000 | $46,799,000 |
| Invested Capital | $41,453,000 | $12,553,000 | $56,465,000 | $76,759,000 |
| Working Capital | $7,182,000 | $12,078,000 | $53,380,000 | $70,325,000 |
| Total Capitalization | $26,990,000 | $12,553,000 | $56,465,000 | $75,132,000 |
| Additional Paid In Capital | $481,676,000 | $454,759,000 | $451,150,000 | $428,605,000 |
| Capital Stock | $315,000 | $135,000 | $126,000 | $122,000 |
| Common Stock | $315,000 | $135,000 | $126,000 | $122,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $2,651,000 | $7,761,000 | $4,346,000 | $1,165,000 |
| Net PPE | $23,000 | $51,000 | $69,000 | $91,000 |
| Accumulated Depreciation | $-340,000 | $-315,000 | $-284,000 | $-286,000 |
| Gross PPE | $363,000 | $366,000 | $353,000 | $377,000 |
| Leases | $148,000 | $148,000 | $148,000 | $148,000 |
| Machinery Furniture Equipment | $215,000 | $218,000 | $205,000 | $143,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $0 | $17,859,000 | $39,712,000 | $53,935,000 |
| Other Properties | - | - | - | $86,000 |
Fetched: 2026-03-28
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-26,772,000 | $-39,343,000 | $-18,535,000 | $-15,903,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-26,770,000 | $-39,330,000 | $-18,473,000 | $-15,842,000 |
| Cash Flow From Continuing Operating Activities | $-26,770,000 | $-39,330,000 | $-18,473,000 | $-15,842,000 |
| Operating Gains Losses | $3,269,000 | $-11,056,000 | $-5,458,000 | $60,964,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,000 | $-13,000 | $-62,000 | $-61,000 |
| Investing Cash Flow | $18,208,000 | $23,336,000 | $13,957,000 | $-54,595,000 |
| Cash Flow From Continuing Investing Activities | $18,208,000 | $23,336,000 | $13,957,000 | $-54,595,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $26,691,000 | $1,034,000 | $433,000 | $89,643,000 |
| Financing Cash Flow | $26,691,000 | $1,034,000 | $-1,818,000 | $83,127,000 |
| Cash Flow From Continuing Financing Activities | $26,691,000 | $1,034,000 | $-1,818,000 | $83,127,000 |
| Net Common Stock Issuance | $26,691,000 | $1,034,000 | $433,000 | $89,643,000 |
| Common Stock Issuance | $26,691,000 | $1,034,000 | $433,000 | $89,643,000 |
| Other | ||||
| Repayment Of Debt | $0 | $0 | $-2,251,000 | $-6,516,000 |
| Interest Paid Supplemental Data | $0 | $0 | $22,000 | $416,000 |
| Income Tax Paid Supplemental Data | $220,000 | $401,000 | $821,000 | $435,000 |
| End Cash Position | $24,159,000 | $6,105,000 | $21,126,000 | $27,510,000 |
| Beginning Cash Position | $6,105,000 | $21,126,000 | $27,510,000 | $14,816,000 |
| Effect Of Exchange Rate Changes | $-75,000 | $-61,000 | $-50,000 | $4,000 |
| Changes In Cash | $18,129,000 | $-14,960,000 | $-6,334,000 | $12,690,000 |
| Net Issuance Payments Of Debt | $0 | $0 | $-2,251,000 | $-6,516,000 |
| Net Long Term Debt Issuance | $0 | $0 | $-2,251,000 | $-6,516,000 |
| Long Term Debt Payments | $0 | $0 | $-2,251,000 | $-6,516,000 |
| Net Investment Purchase And Sale | $18,210,000 | $23,349,000 | $14,019,000 | $-54,534,000 |
| Sale Of Investment | $30,600,000 | $64,528,000 | $59,727,000 | $12,500,000 |
| Purchase Of Investment | $-12,390,000 | $-41,179,000 | $-45,708,000 | $-67,034,000 |
| Net PPE Purchase And Sale | $-2,000 | $-13,000 | $-62,000 | $-61,000 |
| Purchase Of PPE | $-2,000 | $-13,000 | $-62,000 | $-61,000 |
| Change In Working Capital | $-12,731,000 | $2,763,000 | $2,311,000 | $-440,000 |
| Change In Other Working Capital | $155,000 | $271,000 | $-510,000 | $271,000 |
| Change In Other Current Liabilities | $-385,000 | $-354,000 | $-708,000 | $-1,112,000 |
| Change In Other Current Assets | $17,000 | $322,000 | $0 | $-8,000 |
| Change In Payables And Accrued Expense | $-9,855,000 | $5,712,000 | $5,080,000 | $-599,000 |
| Change In Accrued Expense | $-5,110,000 | $3,489,000 | $3,185,000 | $-662,000 |
| Change In Payable | $-4,745,000 | $2,223,000 | $1,895,000 | $63,000 |
| Change In Account Payable | $-4,745,000 | $2,223,000 | $1,895,000 | $63,000 |
| Change In Prepaid Assets | $-2,663,000 | $-3,188,000 | $-1,551,000 | $1,008,000 |
| Other Non Cash Items | $7,171,000 | $5,945,000 | $5,383,000 | $8,139,000 |
| Stock Based Compensation | $363,000 | $784,000 | $22,108,000 | $4,319,000 |
| Amortization Of Securities | $-352,000 | $-1,145,000 | $-183,000 | $636,000 |
| Depreciation Amortization Depletion | $284,000 | $1,750,000 | $1,800,000 | $2,104,000 |
| Depreciation And Amortization | $284,000 | $1,750,000 | $1,800,000 | $2,104,000 |
| Amortization Cash Flow | $254,000 | $1,719,000 | $1,716,000 | $1,713,000 |
| Amortization Of Intangibles | $254,000 | $1,719,000 | $1,716,000 | $1,713,000 |
| Depreciation | $30,000 | $31,000 | $84,000 | $391,000 |
| Gain Loss On Investment Securities | $3,269,000 | $-11,056,000 | $-5,458,000 | $60,964,000 |
| Net Income From Continuing Operations | $-24,774,000 | $-38,371,000 | $-44,434,000 | $-91,564,000 |
| Issuance Of Debt | - | - | $0 | $0 |
| Long Term Debt Issuance | - | - | $0 | $0 |
| Proceeds From Stock Option Exercised | - | - | - | $0 |
Fetched: 2026-03-28